MetLife (MET)
(Delayed Data from NYSE)
$79.16 USD
+0.09 (0.11%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $79.18 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MET 79.16 +0.09(0.11%)
Will MET be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MET based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MET
MET Adds Cancer Support Benefit to Upgrade Critical Illness Plan
Berkshire Boosts Mitsubishi Stake, Increases Investment in Japan
MET: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Berkshire Hathaway is Expanding Its Investments in Japan?
MetLife Q2 Earnings Lag Estimates on Soft MetLife Holdings Unit
Compared to Estimates, MetLife (MET) Q2 Earnings: A Look at Key Metrics
Other News for MET
Is MET signaling a buying opportunity? 50 Day Moving Average Support shows up after advancing 0.11%
Piper Sandler Downgrades MetLife (MET) Citing Lack of Catalysts
MetLife cut to Neutral at Piper as catalysts are well-known, lower rates may boost competition
Intel downgraded, Tesla upgraded: Wall Street’s top analyst calls
Intel downgraded, Tesla upgraded: Wall Street's top analyst calls